Application of lidocaine in alleviating breakthrough pain during epidural labor analgesia in obese primiparas
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 12
Abstract
Objective To evaluate the clinical efficacy of lidocaine in alleviating breakthrough pain during labor in obese primiparas and its effect on maternal and infant outcomes. Methods A total of 120 obese primiparas (body mass index being 35 to 45 kg/m2) underwent epidural analgesia during delivery at Nanjing Women and Children’s Healthcare Hospital from October 2022 to December 2023 were selected and all primiparas experienced breakthrough pain during the first stage of labor. All patients were randomly divided into two groups, with 60 cases in each group. The experimental group received 6 mL of 1.0% lidocaine administered by epidural injection when breakthrough pain occurred (VAS score≥4), while the control group received 6 mL of 0.15% ropivacaine by epidural injection. The following parameters were recorded: time for VAS scores decreasing to 3 or below, cervical dilation at the onset of the first breakthrough pain, number of additional drug administrations during labor, VAS scores at various time points, delivery-related outcomes (duration of labor, use rate of oxytocin, blood loss within 2 hours after delivery, mode of delivery), and adverse events during analgesia. Results Compared with the control group, the experimental group had a shorter time for the VAS score decreasing to 3 or below [7(6,7) min vs 16(16,17) min, Z=52.624, P＜0.01]. There was no statistically significant difference in the cervical dilation at the onset of the first breakthrough pain and number of additional drug administrations during labor (P＞0.05). At 5 min (T1), 10 min (T2), and 15 min (T3) after administration, the VAS scores of the experimental group were lower than those of the control group (P＜0.05). There was no statistically significant difference in the duration of labor, usage rate of oxytocin, blood loss within 2 hours after delivery, mode of delivery, and adverse events during analgesia between the two groups (P＞0.05). Conclusion Both 6 mL of 1.0% lidocaine and 6 mL of 0.15% ropivacaine administered by epidural injection can effectively suppress breakthrough pain in obese parturient during epidural labor analgesia, and improve maternal and neonatal outcomes. And lidocaine demonstrates a shorter onset time, and a faster decrease in VAS score.
Authors and Affiliations
QIAN Xiali, CHEN Yajie, WANG Xian, FENG Shanwu, ZHAO Lin
Keywords
Related Articles
- EP ID EP753803
- DOI 10.13429/j.cnki.cjcr.2024.12.007
- Views 17
- Downloads 0
Research progress of left bundle branch block
Left bundle branch block (LBBB) is an important cause of heart failure. When LBBB occurs, the excitation sequence of the left ventricle changes, leading to the change of cardiac systolic pattern, resulting in cardiac ele...
Visual analysis of domestic and international hotspots of nutritional research in children with tumors
<b>Objective</b> To analyze the literatures related to the nutrition of children with tumors at home and abroad, and sort out the current status, hotspots and frontiers of the research in this field, so as to provide a...
Comparison of the efficacy and safety of programmed cell death protein 1 inhibitors combined with albumin-paclitaxel with or without platinum in the treatment of advanced metastasis or recurrent cervical cancer
<b>Objective</b> To compare the efficacy and safety of programmed cell death protein 1 (PD-1) inhibitor + albumin paclitaxel and platinum + PD-1 inhibitor + albumin-paclitaxel in the treatment of advanced metastasis or r...
Relationship of vascular endothelial growth factor expression and microvessel density with clinicopathological features of triple-negative breast cancer
"Objective To detect the expression of vascular endothelial growth factor (VEGF) and microvessel density in cancer tissues of breast cancer patients, and to analyze their relationship with clinicopathological characteris...
Diagnostic value of three evaluation systems for medium-to-high risk carcinogenesis in chronic atrophic gastritis
"<b>Objective</b> To explore the value of the new gastric cancer screening scoring system, Kimura-Takemoto classification and operative link on gastritis assessment (OLGA) system in assessing the carcinogenesis risk stra...